跳至主要内容
临床试验/NCT03539003
NCT03539003已完成不适用

The Comparison of Changes of QTc, Tp-e Interval, and Tp-e/QT Ratio, Tp-e/QTc Ratio on the ECG During Robotic-assisted Laparoscopic Radical Prostatectomy Under Sevoflurane, Desflurane and Total Intravenous Anesthesia -Randomized Controlled Trial

Yonsei University1 个研究点 分布在 1 个国家目标入组 69 人开始时间: 2018年5月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
69
试验地点
1
主要终点
heart-rate corrected QT(QTc) interval

研究概览

简要总结

The purpose of this study is to compare the changes of QTc, Tp-e interval, and Tp-e/QT ratio, Tp-e/QTc ratio on the ECG during robotic-assisted laparoscopic radical prostatectomy under sevoflurane, desflurane and total intravenous anesthesia

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • ASA class I-III
  • patients undergoing elective robot-assisted laparoscopic radical prostatectomy
  • adult (≥19 years old)

排除标准

  • emergency surgery
  • preoperative QTc prolongation
  • Cardiac disease (unstable angina, congestive heart failure, valvular heart disease)
  • uncontrolled hypertension (DBP >110 mmHg)
  • Patients who take beta blocker
  • Ventricular conduction abnormality
  • Hepatic or renal failure
  • Drug hyperactivity
  • patients unable to understand informed consent (foreigner, illiteracy..)

研究组 & 干预措施

sevoflurane (Group S)

Experimental

general anesthesia with sevoflurane

干预措施: sevoflurane (Drug)

desflurane (Group D)

Active Comparator

general anesthesia with desflurane

干预措施: desflurane (Drug)

total intravenous anesthesia (Group T)

Active Comparator

general anesthesia with total intravenous anesthesia

干预措施: propofol and remifentanil (Drug)

结局指标

主要结局

heart-rate corrected QT(QTc) interval

时间窗: participants will be followed for the duration of surgery, an expected average of 4 hours.

QTc intervals (msec) are recorded from ECG

次要结局

  • Tp-e/QTc ratio(Baseline (T0), 10 min after induction (T1), 5, 15, 30, 45, 60 min after Trendelenburg position (T2-6), 5 min after desufflation and resuming the supine position (T7), end of surgery (T8))
  • Tp-e interval(Baseline (T0), 10 min after induction (T1), 5, 15, 30, 45, 60 min after Trendelenburg position (T2-6), 5 min after desufflation and resuming the supine position (T7), end of surgery (T8))
  • Heart rate(Baseline (T0), 10 min after induction (T1), 5, 15, 30, 45, 60 min after Trendelenburg position (T2-6), 5 min after desufflation and resuming the supine position (T7), end of surgery (T8))
  • blood pressure(Baseline (T0), 10 min after induction (T1), 5, 15, 30, 45, 60 min after Trendelenburg position (T2-6), 5 min after desufflation and resuming the supine position (T7), end of surgery (T8))
  • Tp-e/QT ratio(Baseline (T0), 10 min after induction (T1), 5, 15, 30, 45, 60 min after Trendelenburg position (T2-6), 5 min after desufflation and resuming the supine position (T7), end of surgery (T8))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验